The quantitative polymerase chain reaction (qpcr) instruments market size has grown rapidly in recent years. It will grow from $1.66 billion in 2025 to $1.83 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to rising demand for genetic research, increasing prevalence of infectious diseases, advancements in molecular diagnostics, growth of biotech and pharma research, availability of skilled laboratory workforce.
The quantitative polymerase chain reaction (qpcr) instruments market size is expected to see rapid growth in the next few years. It will grow to $2.69 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing adoption of point-of-care diagnostics, expansion of molecular testing in emerging markets, integration of ai and cloud-based analytics, demand for rapid pathogen detection, rising government funding for genomics research. Major trends in the forecast period include high-throughput testing adoption, integration of automation in qpcr workflows, miniaturization of qpcr instruments, demand for multiplexing capabilities, development of point-of-care qpcr solutions.
The rising incidence of infectious diseases is expected to drive the growth of the quantitative polymerase chain reaction (qPCR) instruments market in the future. Infectious diseases are caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly between individuals. The increase in infectious diseases is largely due to the growth in global travel, which accelerates the spread of pathogens across borders. Quantitative polymerase chain reaction (qPCR) instruments assist in combating infectious diseases by providing rapid, sensitive, and precise detection of pathogens, enabling timely diagnosis and effective management of diseases. For example, in February 2024, GOV.UK, a UK government department, reported that tuberculosis (TB) cases in England rose from 4,380 in 2022 to 4,850 in 2023. Hence, the growing incidence of infectious diseases is propelling the expansion of the qPCR instruments market.
Major companies operating in the Quantitative Polymerase Chain Reaction (qPCR) Instruments market are concentrating on creating innovative solutions, such as next-generation real-time qPCR systems that integrate clinical-grade workflows with research adaptability, to address the growing need for faster, higher-throughput molecular diagnostics, enhanced assay sensitivity for personalized medicine and oncology, and improved outbreak preparedness for infectious disease testing. A next-generation qPCR system is a real-time PCR instrument that maintains the fundamental principle of qPCR (simultaneous nucleic acid amplification and fluorescent detection) while incorporating features such as superior thermal uniformity, advanced signal-processing algorithms, user-friendly interfaces, and regulatory-ready IVD workflows. For example, in November 2023, Roche Holding AG, a Switzerland-based diagnostics and biotechnology company, introduced the LightCycler PRO System, a cutting-edge next-generation qPCR platform. The LightCycler PRO System builds on Roche’s LightCycler legacy and is designed for both research and IVD applications, offering a new vapor chamber to enhance temperature uniformity across the block, updated software and user interface with improved signal analysis algorithms, and the versatility to run user-developed assays alongside an extensive collection of validated LightMix research and CE-IVD assays.
In April 2023, Thermo Fisher Scientific Inc., a US-based life sciences and clinical research company, formed a partnership with ALPCO-GeneProof to broaden access to PCR diagnostic solutions. Through this collaboration, Thermo Fisher aims to expand its molecular diagnostics portfolio by increasing its CE-IVD assay offerings and strengthening its presence in the European clinical testing market. ALPCO-GeneProof is a US-based diagnostics firm specializing in both molecular and immunodiagnostic solutions.
Major companies operating in the quantitative polymerase chain reaction (qpcr) instruments market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc, Bio Rad Laboratories Inc, QIAGEN N V, Eppendorf SE, Cepheid Inc, Takara Bio Inc, bioMerieux SA, Analytik Jena GmbH, Standard BioTools Inc, Hangzhou Bioer Technology Co Ltd, BioTeke Corporation, GeneReach Biotechnology Corp, Anitoa Systems LLC, Blue Ray Biotech Corp, Chai Biotechnologies, Bio Molecular Systems Pty Ltd, Azure Biosystems Inc.
North America was the largest region in the quantitative polymerase chain reaction (qPCR) instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the quantitative polymerase chain reaction (qpcr) instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the quantitative polymerase chain reaction (qpcr) instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have created challenges for the qPCR instruments market by increasing the cost of importing high-precision instruments and reagents, particularly affecting real-time qPCR systems and digital PCR systems. Regions such as North America, Europe, and Asia-Pacific, which rely heavily on cross-border trade for advanced qPCR technologies, are most impacted. Diagnostic laboratories, hospitals, and biotech companies face higher operational costs and potential delays in instrument procurement. On the positive side, tariffs are encouraging some local manufacturing and assembly initiatives, which could lead to regional supply chain resilience and innovation in cost-effective qPCR solutions.
The quantitative polymerase chain reaction (qpcr) instruments market research report is one of a series of new reports that provides quantitative polymerase chain reaction (qpcr) instruments market statistics, including quantitative polymerase chain reaction (qpcr) instruments industry global market size, regional shares, competitors with a quantitative polymerase chain reaction (qpcr) instruments market share, detailed quantitative polymerase chain reaction (qpcr) instruments market segments, market trends and opportunities, and any further data you may need to thrive in the quantitative polymerase chain reaction (qpcr) instruments industry. This quantitative polymerase chain reaction (qpcr) instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Quantitative polymerase chain reaction (qPCR) instruments are specialized laboratory devices used to amplify and simultaneously quantify specific DNA sequences in real time. These instruments track DNA accumulation during each amplification cycle through fluorescent signals, enabling researchers to measure DNA amounts with high sensitivity and precision. They are vital tools in molecular biology, diagnostics, and research for applications including gene expression analysis, pathogen detection, and genetic variation studies.
The main product types of quantitative polymerase chain reaction (qPCR) instruments include quantitative polymerase chain reaction systems, reagents and consumables, and software. Quantitative polymerase chain reaction systems are laboratory instruments designed to amplify and quantify DNA or RNA sequences in real time using fluorescence-based detection. These systems include models such as the 7500, ViiA 7 Dx, Cobas 4800, CFX96, SmartCycler, GeneXpert, Rotor-Gene Q, Rotor-Gene Q 5plex HRM System, BioFire FilmArray systems, and others. They are applied in various fields like gene expression analysis, genotyping, pathogen detection, and diagnostics, and are utilized by end users including diagnostic laboratories, hospitals and clinics, pharmaceutical and biotechnology companies, among others.
The quantitative polymerase chain reaction (qPCR) instrument market consists of revenues earned by entities providing services such as analysis software, installation and training, technical support, and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The quantitative polymerase chain reaction (qPCR) instrument market also includes sales of thermal cyclers, optical detection systems, reaction tubes and plates, and analysis software. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The quantitative polymerase chain reaction (qpcr) instruments market size is expected to see rapid growth in the next few years. It will grow to $2.69 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing adoption of point-of-care diagnostics, expansion of molecular testing in emerging markets, integration of ai and cloud-based analytics, demand for rapid pathogen detection, rising government funding for genomics research. Major trends in the forecast period include high-throughput testing adoption, integration of automation in qpcr workflows, miniaturization of qpcr instruments, demand for multiplexing capabilities, development of point-of-care qpcr solutions.
The rising incidence of infectious diseases is expected to drive the growth of the quantitative polymerase chain reaction (qPCR) instruments market in the future. Infectious diseases are caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly between individuals. The increase in infectious diseases is largely due to the growth in global travel, which accelerates the spread of pathogens across borders. Quantitative polymerase chain reaction (qPCR) instruments assist in combating infectious diseases by providing rapid, sensitive, and precise detection of pathogens, enabling timely diagnosis and effective management of diseases. For example, in February 2024, GOV.UK, a UK government department, reported that tuberculosis (TB) cases in England rose from 4,380 in 2022 to 4,850 in 2023. Hence, the growing incidence of infectious diseases is propelling the expansion of the qPCR instruments market.
Major companies operating in the Quantitative Polymerase Chain Reaction (qPCR) Instruments market are concentrating on creating innovative solutions, such as next-generation real-time qPCR systems that integrate clinical-grade workflows with research adaptability, to address the growing need for faster, higher-throughput molecular diagnostics, enhanced assay sensitivity for personalized medicine and oncology, and improved outbreak preparedness for infectious disease testing. A next-generation qPCR system is a real-time PCR instrument that maintains the fundamental principle of qPCR (simultaneous nucleic acid amplification and fluorescent detection) while incorporating features such as superior thermal uniformity, advanced signal-processing algorithms, user-friendly interfaces, and regulatory-ready IVD workflows. For example, in November 2023, Roche Holding AG, a Switzerland-based diagnostics and biotechnology company, introduced the LightCycler PRO System, a cutting-edge next-generation qPCR platform. The LightCycler PRO System builds on Roche’s LightCycler legacy and is designed for both research and IVD applications, offering a new vapor chamber to enhance temperature uniformity across the block, updated software and user interface with improved signal analysis algorithms, and the versatility to run user-developed assays alongside an extensive collection of validated LightMix research and CE-IVD assays.
In April 2023, Thermo Fisher Scientific Inc., a US-based life sciences and clinical research company, formed a partnership with ALPCO-GeneProof to broaden access to PCR diagnostic solutions. Through this collaboration, Thermo Fisher aims to expand its molecular diagnostics portfolio by increasing its CE-IVD assay offerings and strengthening its presence in the European clinical testing market. ALPCO-GeneProof is a US-based diagnostics firm specializing in both molecular and immunodiagnostic solutions.
Major companies operating in the quantitative polymerase chain reaction (qpcr) instruments market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc, Bio Rad Laboratories Inc, QIAGEN N V, Eppendorf SE, Cepheid Inc, Takara Bio Inc, bioMerieux SA, Analytik Jena GmbH, Standard BioTools Inc, Hangzhou Bioer Technology Co Ltd, BioTeke Corporation, GeneReach Biotechnology Corp, Anitoa Systems LLC, Blue Ray Biotech Corp, Chai Biotechnologies, Bio Molecular Systems Pty Ltd, Azure Biosystems Inc.
North America was the largest region in the quantitative polymerase chain reaction (qPCR) instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the quantitative polymerase chain reaction (qpcr) instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the quantitative polymerase chain reaction (qpcr) instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have created challenges for the qPCR instruments market by increasing the cost of importing high-precision instruments and reagents, particularly affecting real-time qPCR systems and digital PCR systems. Regions such as North America, Europe, and Asia-Pacific, which rely heavily on cross-border trade for advanced qPCR technologies, are most impacted. Diagnostic laboratories, hospitals, and biotech companies face higher operational costs and potential delays in instrument procurement. On the positive side, tariffs are encouraging some local manufacturing and assembly initiatives, which could lead to regional supply chain resilience and innovation in cost-effective qPCR solutions.
The quantitative polymerase chain reaction (qpcr) instruments market research report is one of a series of new reports that provides quantitative polymerase chain reaction (qpcr) instruments market statistics, including quantitative polymerase chain reaction (qpcr) instruments industry global market size, regional shares, competitors with a quantitative polymerase chain reaction (qpcr) instruments market share, detailed quantitative polymerase chain reaction (qpcr) instruments market segments, market trends and opportunities, and any further data you may need to thrive in the quantitative polymerase chain reaction (qpcr) instruments industry. This quantitative polymerase chain reaction (qpcr) instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Quantitative polymerase chain reaction (qPCR) instruments are specialized laboratory devices used to amplify and simultaneously quantify specific DNA sequences in real time. These instruments track DNA accumulation during each amplification cycle through fluorescent signals, enabling researchers to measure DNA amounts with high sensitivity and precision. They are vital tools in molecular biology, diagnostics, and research for applications including gene expression analysis, pathogen detection, and genetic variation studies.
The main product types of quantitative polymerase chain reaction (qPCR) instruments include quantitative polymerase chain reaction systems, reagents and consumables, and software. Quantitative polymerase chain reaction systems are laboratory instruments designed to amplify and quantify DNA or RNA sequences in real time using fluorescence-based detection. These systems include models such as the 7500, ViiA 7 Dx, Cobas 4800, CFX96, SmartCycler, GeneXpert, Rotor-Gene Q, Rotor-Gene Q 5plex HRM System, BioFire FilmArray systems, and others. They are applied in various fields like gene expression analysis, genotyping, pathogen detection, and diagnostics, and are utilized by end users including diagnostic laboratories, hospitals and clinics, pharmaceutical and biotechnology companies, among others.
The quantitative polymerase chain reaction (qPCR) instrument market consists of revenues earned by entities providing services such as analysis software, installation and training, technical support, and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The quantitative polymerase chain reaction (qPCR) instrument market also includes sales of thermal cyclers, optical detection systems, reaction tubes and plates, and analysis software. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Characteristics
3. Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Supply Chain Analysis
4. Global Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Trends and Strategies
5. Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Analysis of End Use Industries
7. Global Quantitative Polymerase Chain Reaction (qPCR) Instruments Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Quantitative Polymerase Chain Reaction (qPCR) Instruments Total Addressable Market (TAM) Analysis for the Market
9. Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Segmentation
10. Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Regional and Country Analysis
11. Asia-Pacific Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
12. China Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
13. India Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
14. Japan Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
15. Australia Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
16. Indonesia Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
17. South Korea Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
18. Taiwan Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
19. South East Asia Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
20. Western Europe Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
21. UK Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
22. Germany Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
23. France Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
24. Italy Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
25. Spain Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
26. Eastern Europe Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
27. Russia Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
28. North America Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
29. USA Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
30. Canada Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
31. South America Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
32. Brazil Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
33. Middle East Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
34. Africa Quantitative Polymerase Chain Reaction (qPCR) Instruments Market
36. Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Competitive Landscape and Company Profiles
37. Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Other Major and Innovative Companies
40. Quantitative Polymerase Chain Reaction (qPCR) Instruments Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses quantitative polymerase chain reaction (qpcr) instruments market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for quantitative polymerase chain reaction (qpcr) instruments? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The quantitative polymerase chain reaction (qpcr) instruments market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Quantitative Polymerase Chain Reaction Systems; Reagents And Consumables; Software2) By Instrument: 7500; Viia 7 Dx; Cobas 4800; Cfx96; Smartcycler; Genexpert; Rotor-Gene Q; Rotor-Gene Q 5plex Hrm System; Biofire Filmarray Systems; Other Instruments
3) By Application: Gene Expression; Genotyping; Pathogen Detection; Diagnostics; Other Applications
4) By End-Users: Diagnostic Laboratories; Hospitals And Clinics; Pharma And Biotech Companies; Other End-Users
Subsegments:
1) By Quantitative Polymerase Chain Reaction (qPCR) Systems: Real-Time Polymerase Chain Reaction Systems; Portable Or Compact qPCR Devices; Digital Polymerase Chain Reaction Systems2) By Reagents And Consumables: Master Mixes; Buffers And Enzymes; Primers
3) By Software: Data Analysis Software; Cloud-Based Analytics Platforms; Instrument Control Software
Companies Mentioned: F Hoffmann La Roche AG; Thermo Fisher Scientific Inc; Danaher Corporation; Becton Dickinson and Company; Agilent Technologies Inc; Bio Rad Laboratories Inc; QIAGEN N V; Eppendorf SE; Cepheid Inc; Takara Bio Inc; bioMerieux SA; Analytik Jena GmbH; Standard BioTools Inc; Hangzhou Bioer Technology Co Ltd; BioTeke Corporation; GeneReach Biotechnology Corp; Anitoa Systems LLC; Blue Ray Biotech Corp; Chai Biotechnologies; Bio Molecular Systems Pty Ltd; Azure Biosystems Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Quantitative Polymerase Chain Reaction (qPCR) Instruments market report include:- F Hoffmann La Roche AG
- Thermo Fisher Scientific Inc
- Danaher Corporation
- Becton Dickinson and Company
- Agilent Technologies Inc
- Bio Rad Laboratories Inc
- QIAGEN N V
- Eppendorf SE
- Cepheid Inc
- Takara Bio Inc
- bioMerieux SA
- Analytik Jena GmbH
- Standard BioTools Inc
- Hangzhou Bioer Technology Co Ltd
- BioTeke Corporation
- GeneReach Biotechnology Corp
- Anitoa Systems LLC
- Blue Ray Biotech Corp
- Chai Biotechnologies
- Bio Molecular Systems Pty Ltd
- Azure Biosystems Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.83 Billion |
| Forecasted Market Value ( USD | $ 2.69 Billion |
| Compound Annual Growth Rate | 10.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
